Healthcare GTM Operating System
Editorial revision: . Original publication and source dates are retained.
Connect market demand, reimbursement, provider workflows, sales evidence, and delivery capacity so leadership can decide which commercial approach deserves further investment.
Return to insightsHealthtech CEOs, founders, and commercial leaders building repeatable go-to-market motion. / Evergreen framework
The strategic question
Which customer cohort justifies the next commitment of sales, delivery and working capital?
A go-to-market system should explain which buyers can act, what implementation requires, and which evidence justifies expansion. Use those decisions to align sales, operations, and finance.
Operating model
Allocate growth capital by delivery cohort.
I treat go-to-market as an allocation system: it decides which demand the organization pursues and which delivery obligations it accepts. A growing pipeline can conceal a deteriorating business if the new customers require more customization, longer cash cycles or capacity the company does not have. The relevant unit is a customer cohort carried from qualification through implementation, recurring use, collection and renewal.
That cohort needs a reconciled economic record. Acquisition cost includes the selling effort required to win the account; implementation and ongoing service costs belong in delivery economics. Mixing them can make acquisition look efficient while margin deteriorates after signature. I would also separate contracted revenue from collectible revenue and test the cash required between committing staff and receiving payment. A growth plan that clears a contribution-margin threshold can still consume more working capital than the company can finance.
The operating decision is which constraint deserves the next dollar. When demand is credible and launches are delayed, implementation capacity may dominate additional sales hiring. When launches succeed but renewal depends on discounts or founder intervention, the offer or segment needs revision. I would fund expansion only after the team can explain why the next cohort should be easier or more profitable to serve, which assumption supports that conclusion, and what result would reverse it.
Operating framework
- 01
Group accounts by a comparable purchase and delivery model; distinguish expressions of interest from funded commitments.
- 02
Underwrite each cohort through implementation, recurring service, collection and renewal, including the cash consumed between milestones.
- 03
Reconcile signed contracts with launch capacity and collected contribution before expanding the selling organization.
- 04
Release growth capital against the constraint that evidence identifies: demand, implementation, retention or delivery economics.
Metrics that matter
- 01
Funded demand by customer cohort and contract type
- 02
Contract-to-live conversion and cancellation by cohort
- 03
Delivery contribution after implementation and support
- 04
Peak cash requirement through collection and renewal
Red flags
Contracted backlog requires implementation capacity that the growth budget has not funded.
Reported sales efficiency excludes custom delivery or discounts needed to secure renewal.
The next hiring plan assumes repeatability that the last customer cohort did not demonstrate.
CEO and CFO questions
Which cohort produces the strongest collected contribution for the capital and delivery capacity it consumes?
Would another sales hire increase profitable service volume or enlarge an unfunded implementation queue?
Which cohort result would cause us to narrow the offer, change price or stop acquisition spending?
Discuss the strategic decision